Keywords: wyeth, showcases, novel, antibiotic, tigecycline, activity, against

Wyeth showcases novel antibiotic tigecycline, with activity against MRSA

Article | 15 November 2004

Print This

A new, first-in-class intravenous antibiotic, tigecycline, one of only three developed since the 1960s, was profiled this month by Wyeth ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in